title: [Do new oral therapies show advantages in the basal therapy of multiple sclerosis? Con].
authors.affiliation: Neurologische Klinik, Universitätsklinikum Erlangen, Schwabachanlage 6, 91052, Erlangen, Deutschland, ralf.linker@uk-erlangen.de.
authors.forename: R A
authors.initials: RA
authors.lastname: Linker
mesh_terms: D000284:Administration, Oral; D019317:Evidence-Based Medicine; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D009103:Multiple Sclerosis / Q000175:diagnosis* / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents